
Should All COPD and Asthma Patients Be Screened for Alpha-1?

Should All COPD and Asthma Patients Be Screened for Alpha-1? is organized by Projects In Knowledge Inc. (PIK).
Release Date: May 08, 2023
Termination Date: May 07, 2024
Activity Goal:
The goal of this activity series is to raise awareness of and improve understanding of AATD among physicians and patients toward guideline recommendations for early testing, diagnosis, and treatment of AATD through expert commentary and analysis.
Learning Objective(s):
• Discuss the epidemiology of Alpha-1 antitrypsin deficiency (AATD) and the burden associated with the disease.
• Apply guideline-recommended screening strategies in at-risk patients to ensure early identification and treatment of AATD.
Additional details will be posted as soon as information is available.